Oppenheimer & Co’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,775
Closed -$327K 1351
2019
Q4
$327K Buy
5,775
+2,031
+54% +$113K 0.01% 991
2019
Q3
$200K Sell
3,744
-34,375
-90% -$1.85M 0.01% 1146
2019
Q2
$2.23M Buy
38,119
+1,300
+4% +$69.8K 0.06% 363
2019
Q1
$1.83M Sell
36,819
-250
-0.7% -$11K 0.05% 412
2018
Q4
$1.38M Sell
37,069
-3,100
-8% -$113K 0.04% 429
2018
Q3
$1.52M Buy
40,169
+27,081
+207% +$1.13M 0.04% 470
2018
Q2
$573K Buy
+13,088
New +$615K 0.02% 811

Other funds holding XRAY

Oppenheimer & Co's XRAY Position: Q1 2020 in Review

Oppenheimer & Co sold out of Dentsply Sirona (XRAY) in Q1 2020, closing a stake of 5,775 shares — an estimated $327K sold.

Oppenheimer & Co first reported a position in XRAY in Q2 2018 and held it in 7 quarters. The position peaked at $2.23M in Q2 2019. 516 funds tracked by Wall St. Rank hold XRAY as of Q1 2020.

  • Oppenheimer & Co reported no remaining Dentsply Sirona position as of Q1 2020 after selling out during the quarter.
  • Oppenheimer & Co sold 5,775 Dentsply Sirona shares in Q1 2020, an estimated $327K.
  • Oppenheimer & Co first reported a position in Dentsply Sirona in Q2 2018 and held it in 7 quarters.
  • Oppenheimer & Co's Dentsply Sirona position peaked at $2.23M in Q2 2019.
  • 516 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2020.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.